Multi-kinase-IN-4

Multi-kinase-IN-4 is a multi-targeted kinase inhibitor with potent activity against VEGFR2, EGFR, HER2, and CDK2. It demonstrates broad-spectrum anti-proliferative effects in various cancer cell lines, induces apoptosis and S-phase arrest, and shows selectivity over normal cells, supporting its utility in cancer research.